Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume -, Issue -, Pages 1-6
Publisher
Informa UK Limited
Online
2020-04-11
DOI
10.1080/09546634.2020.1755008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ustekinumab with Intravenous Infusion: Results in Hidradenitis Suppurativa
- (2019) Jorge Romaní et al. DERMATOLOGY
- Ustekinumab treatment for hidradenitis suppurativa
- (2019) Kana Takeda et al. JOURNAL OF DERMATOLOGY
- Hidradenitis suppurativa/acne inversa: A practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group
- (2018) C.C. Zouboulis et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum
- (2016) J.L. Blok et al. BRITISH JOURNAL OF DERMATOLOGY
- HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
- (2015) A.B. Kimball et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
- (2015) C.C. Zouboulis et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Management of Recalcitrant Hidradenitis Suppurativa with Ustekinumab
- (2013) V Sharon et al. ACTA DERMATO-VENEREOLOGICA
- Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support
- (2013) F.W. Danby et al. BRITISH JOURNAL OF DERMATOLOGY
- Successful long-term triple disease control by ustekinumab in a patient with Behçet's disease, psoriasis and hidradenitis suppurativa: Table 1
- (2012) Ewout M Baerveldt et al. ANNALS OF THE RHEUMATIC DISEASES
- Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
- (2011) H.H. van der Zee et al. BRITISH JOURNAL OF DERMATOLOGY
- Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
- (2011) Christoph Schlapbach et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa
- (2011) W.P. Gulliver et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Hidradenitis suppurativa: A comprehensive review
- (2009) Ali Alikhan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started